Company intelligence / Profile preview

COARE Biotechnology

Oklahoma City, Oklahoma, United Statesdnb.com ↗

Ownership: Private
Development stage: Preclinical

Overview

COARE is a pre-clinical stage biotechnology company developing novel therapeutic drugs to treat pancreatic cancer, focusing on targeting tumor-initiating cells in solid tumor cancers[6].

Therapeutic areas: Oncology
Modalities: Monoclonal antibodies (humanized mAb)
Industry: Biotech

Drug pipeline

1 asset

CBT-15G

Preclinical

Beyond the preview

Go deeper on COARE Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on COARE Biotechnology.

Explore the full profile